The latest price target for Core Laboratories (NYSE:CLB) was reported by Stifel on July 26, 2024. The analyst firm set a price target for $22.00 expecting CLB to rise to within 12 months (a possible 19.76% upside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for Core Laboratories (NYSE:CLB) was provided by Stifel, and Core Laboratories maintained their hold rating.

The last upgrade for Core Laboratories Inc happened on January 9, 2023 when B of A Securities raised their price target to N/A. B of A Securities previously had an underperform for Core Laboratories Inc.

The last downgrade for Core Laboratories Inc happened on June 30, 2023 when Citigroup changed their price target from $22 to $21 for Core Laboratories Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Core Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Core Laboratories was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.

While ratings are subjective and will change, the latest Core Laboratories (CLB) rating was a maintained with a price target of $18.00 to $22.00. The current price Core Laboratories (CLB) is trading at is $18.37, which is within the analyst’s predicted range.